Skip to Main Content

Paper Details

Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction.
ESC Heart Fail
5
2022
HE4, HF, HFrEF, N, N-terminal pro-B-type natriuretic peptide, NT-proBNP, WAP four-disulphide core domain protein, WAP-4C, disulphide, four, heart failure, patients
Author NameAffiliation
Kenneth DicksteinStavanger University Hospital
Kenneth DicksteinUniversity of Bergen
Carolyn S P Lam
Carolyn S P LamDuke-NUS Medical School
Nilesh J SamaniUniversity of Leicester, Glenfield Hospital, and NIHR Leicester Biomedical Research Centre
John G F ClelandInstitute of Health and Wellbeing, University of Glasgow, Glasgow and National Heart & Lung Institute, Imperial College
  • 1 - 6

Datasets

Release 1.2